Medtronic plc's latest moves, explained simply — so you know why the numbers change.
Straight from SEC filings · updated 5 Aug 2026Annual reports show how much money the company made and spent, helping investors understand its health.
Quarterly earnings show if the company is growing or shrinking, which affects its stock value.
Leadership changes can affect company direction and strategy, which matters to investors.
Data breaches can cost money and harm customer trust, but this one did not impact operations.
New product approvals can generate future sales; MiniMed IPO and Blackstone deal impact earnings.
Quarterly earnings show if the company is growing or shrinking, which affects its stock value.
Quarterly earnings show if the company is growing or shrinking, which affects its stock value.
Stocky reads Medtronic plc's official filings with the U.S. Securities and Exchange Commission (SEC) — the 8-K, 10-Q and 10-K reports every public company must file — and summarizes each one in plain English, with a link back to the original document.
Medtronic plc's most recent tracked filing was a 10-K on 18 Jun 2026: Reports fiscal year 2026 financial results and position.
No. These event summaries are educational — generated from public SEC filings to help beginners understand what a company is doing. They are not buy or sell recommendations.
Educational, not financial advice. Company events summarized from public SEC filings.
Data as of 5 Aug 2026.